Literature DB >> 1415687

Effects of differing insulin levels on response to equivalent hypoglycemia in conscious dogs.

S N Davis1, R Dobbins, C Tarumi, C Colburn, D Neal, A D Cherrington.   

Abstract

The aim of this study was to determine if differing concentrations of insulin can modify the counterregulatory response to equivalent hypoglycemia. Insulin was infused intraportally into normal 18-h-fasted conscious dogs at 2 (low, n = 6) or 8 mU.kg-1.min-1 (high, n = 7) on separate occasions. This resulted in steady-state arterial insulin levels of 80 +/- 8 and 610 +/- 55 microU/ml, respectively. Glucose was infused during the high dose to maintain plasma glucose similar to low (50 +/- 1 mg/dl). Despite similar plasma glucose levels, epinephrine (2,589 +/- 260, 806 +/- 180 pg/ml), norepinephrine (535 +/- 60, 303 +/- 55 pg/ml), cortisol (12.1 +/- 1.5, 5.8 +/- 1.2 micrograms/dl), and pancreatic polypeptide (1,198 +/- 150, 598 +/- 250 pg/ml) were all increased in the presence of high-dose insulin (P < 0.05). Glucagon levels were similar during both insulin infusions. Hepatic glucose production, measured with [3-3H]-glucose, rose from 2.6 +/- 0.2 to 4.7 +/- 0.3 mg.kg-1.min-1 in response to high insulin (P < 0.01) but remained unchanged, 3.0 +/- 0.5 mg.kg-1.min-1, during low-dose infusions. Six hyperinsulinemic euglycemic control experiments (2 or 8 mU.kg-1.min-1, n = 3 in each) provided baseline data. By the final hour of the high-dose euglycemic clamps, cortisol (2.4 +/- 0.4 to 4.8 +/- 0.8 micrograms/dl) and norepinephrine (125 +/- 34 to 278 +/- 60 pg/ml) had increased (P < 0.05) compared with baseline. Plasma epinephrine levels remained unchanged during both series of euglycemic studies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415687     DOI: 10.1152/ajpendo.1992.263.4.E688

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.

Authors:  A M Powell; R S Sherwin; G I Shulman
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

2.  Brain insulin infusion does not augment the counterregulatory response to hypoglycemia or glucoprivation.

Authors:  Kent K Ishihara; Samuel C Haywood; Dorit Daphna-Iken; Erwin C Puente; Simon J Fisher
Journal:  Metabolism       Date:  2009-06       Impact factor: 8.694

3.  Glucagon secretion and autonomic signaling during hypoglycemia in late pregnancy.

Authors:  Kathryn M Canniff; Marta S Smith; D Brooks Lacy; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-03-23       Impact factor: 3.619

4.  Evidence that the brain of the conscious dog is insulin sensitive.

Authors:  S N Davis; C Colburn; R Dobbins; S Nadeau; D Neal; P Williams; A D Cherrington
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

5.  Liver glycogen-induced enhancements in hypoglycemic counterregulation require neuroglucopenia.

Authors:  Shana O Warner; Abby M Wadian; Marta Smith; Ben Farmer; Yufei Dai; Nicole Sheanon; Dale S Edgerton; Jason J Winnick
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-03-29       Impact factor: 4.310

6.  Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure.

Authors:  Eric Lontchi-Yimagou; Sandra Aleksic; Raphael Hulkower; Rebekah Gospin; Akankasha Goyal; Bryan Kuo; William G Mitchell; Jee Young You; Laxmi Upadhyay; Michelle Carey; Oana A Sandu; Ilan Gabriely; Harry Shamoon; Meredith Hawkins
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.